Local expression of cytokines in human colorectal carcinoma: Evidence of specific interleukin-6 gene expression

Journal of Immunotherapy

Volumn 22, Issue 1, 1999, Pages 25-32

  Piancatelli, Daniela ^a   Romano, Pina ^a   Sebastiani, Pierluigi ^a   Adorno, Domenico ^a,b   Casciani, Carlo Umberto ^a  

^a CNR Inst Tissue Typing Dialysis   (Italy)

^b CNR Ist Tipizzazione T   (Italy)

Author keywords

Colorectal cancer; Cytokines; Gene expression; Interleukin 6; RT PCR

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INFLAMMATION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; COLON; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; INTERLEUKINS; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032948257     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-199901000-00004     Document Type: Article

References (34)

1. Leong SPL. Immunotherapy of malignant melanoma. Surg Clin N Am 1996;76:1355-81.
2. Stein RC, Dalgleish AG. Immunomodulatory agents: the cytokines. Eur J Cancer 1994;30A:400-4.
3. Brakenhoff JPJ. Interleukin-6 receptor antagonists. Dig Neurol Psych 1995;8:397-403.
4. Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 1992;62:S60-5.
5. Blay JY, Negrier S. Combaret V, et al. Serum levels of interleukin-6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res 1992;52:3317-22.
6. Scambia G, Testa U, Benedetti Panici P, et al. Interleukin-6 serum levels in patients with gynecological tumors. Int J Cancer 1994; 57:318-23.
7. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function and clinical application. Ann Intern Med 1990;113:619-27.
8. Semenzato G, Foa R, Agostini C, et al. High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood 1987;70:396-400.
9. Ambrosetti A, Nadali G, Vinante F, et al. Serum levels of soluble IL-2 receptor in Hodgkin disease. Cancer 1993;72:201-6.
10. Poulakis N, Sarandakou A, Rizos D, Phocas I, Kontozoglou T, Polyzogopoulos D. Soluble interleukin-2 receptors and other markers in primary lung cancer. Cancer 1991;68:1045-9.
11. Piancatelli D, Maccarone D, Del Beato T, Famulari A, Adorno D, Casciani CU. Colorectal cancer and circulating concentrations of soluble lymphocyte activation molecules: relations to disease activity and tumour burden. Int J Immunopath Pharmacol 1996;9: 123-8.
12. Murakami S, Satomi A, Ishida K, Murai H, Okamura Y. Serum soluble interleukin-2 receptor in colorectal cancer. Acta Oncol 1994;33:19-21.
13. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for staging of cancer/American Joint Committee Against Cancer. Philadelphia: JB Lippincott, 1992:75-9.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
15. Ehlers S, Smith KA. Differentiation of T-cell lymphokine gene expression: the in vitro acquisition of T-cell memory. J Exp Med 1991;173:25-36.
16. Filgueira L, Zuber M, Merlo A, et al. Cytokine gene transcription in renal cell carcinoma. Br J Surg 1993;80:1322-5.
17. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277-9.
18. Pisa P, Halapi E, Pisa EK, et al. Selective expression of interleukin 10. interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992; 89:7708-12.
19. Hirano T. Interleukin 6. In: Thomson AW, ed. The cytokine handbook, 2nd ed. New York: Academic Press, 1994:145-68.
20. Tran-Thang C, Kruithof E, Lahm H, Schuster WA, Tada M, Sordat B. Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells. Br J Cancer 1996; 74:846-52.
21. Watson JM, Sensintaffar JL, Berek JS, Martinez-Maza O. Constitutive production of IL-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990;50:6959-65.
22. Oka M, Yamamoto K, Takahashi M, et al. Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 1996;56:2776-80.
23. Tartour E, Gey A, Sastre-Garau X, et al. Analysis of interleukin 6 gene expression in cervical carcinoma using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res 1994;54: 6243-8.
24. Miki S, Iwano M, Miki Y, et al. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989;250:607-10.
25. Okamoto M, Lee C, Oyasu R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res 1997;57:141-6.
26. Basolo F. Fiore L, Fontanini G, et al. Expression of and response to interleukin 6 (IL-6) in human mammary tumors. Cancer Res 1996;56:3118-22.
27. Hibi M, Nakajima K, Hirano T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 1996; 74:1-12.
28. MacDermott RP. Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol 1996;31:907-16.
29. Zier K, Gansbacher B. Salvadori S. Preventing abnormalities in signal transduction of T cells in cancer - the promise of cytokine gene therapy. Immunol Today 1996;17:39-45.
30. Rabinowich H, Suminami Y, Reichert TE, et al. Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma. Int J Cancer 1996;68: 276-84.
31. Morris DL, Adams WJ. Cimetidine and colorectal cancer - old drug, new use? Nature Med 1995;1:1243-4.
32. Uotila P. The role of cyclic AMP and oxigen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother 1996;43:39-43.
33. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-14.
34. McMillan DC, Leen E, Smith J, et al. Effect of extended ibuprofen administration on the acute phase response in colorectal cancer. Eur J Surg Oncol 1995;21:531-4.